Overview

In the two decades since the elusive ""slow reacting substance of anaphylaxis"" (SRS-A) was identified as a product of the action of the 5-lipoxygenase enzyme on arachidonic acid, it has been well established that the leukotrienes are key mediators of both alIergy and inflammation. Their release by alIergen or other challenge has been demonstrated in the lungs of asthmatic subjects, and measurement of urinary leukotriene concentrations in such patients has been shown to be a valuable, non­ invasive indicator. Significant progress has been made towards the characterization of the leukotriene receptor subtypes, exemplified by the cloning of the LTB4 receptor earlier this year. Coupled with this there has been a continued elucidation of signal transduction mechanisms underlying receptor activation. Consequent upon these advances has been the development of potent antagonists of the CysLT receptor, J and both these and inhibitors of leukotriene biosynthesis have entered clinical practice in the therapy of asthma. In this clinical setting antagonists of the CysLTJ receptor have been shown to be an effective therapy in chronic asthmatics, against antigen- and exercise-induced bronchoconstriction, and in aspirin-intolerant asthmatics. The advent of this new class of agents promises to change the way in which asthmatic patients are currently treated.

Full Product Details

Author:   Ian Rodger ,  Jack H. Botting ,  Sven-Erik Dahlén
Publisher:   Springer
Imprint:   Springer
Edition:   Softcover reprint of the original 1st ed. 1998
Dimensions:   Width: 15.50cm , Height: 0.80cm , Length: 23.50cm
Weight:   0.248kg
ISBN:  

9789401060455

ISBN 10:   9401060452
Pages:   143
Publication Date:   03 October 2013
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1 Molecular mechanisms of leukotriene synthesis: the changing paradigm.- 2 Leukotriene receptors.- 3 Enzymes involved in the production of leukotrienes and related molecules.- 4 Cysteinyl-leukotriene receptors and transduction mechanisms in airway cells.- 5 How to measure leukotrienes in man.- 6 Influence of leukotrienes and anti-leukotrienes on airway tone and migration of inflammatory cells.- 7 Leukotrienes in airways obstruction and inflammation evoked by allergen.- 8 Leukotrienes in induced airway obstruction.- 9 Role of leukotrienes in aspirin-induced asthma.- 10 How to use anti-leukotrienes in the treatment of asthma.- 11 Transcription factors HSF and HF-?B as targets for cytoprotective eicosanoids: a new strategy for therapeutic intervention.- 12 Vascular biology of the leukotrienes.- 13 Leukotrienes in cardiovascular disease.- 14 Leukotriene B4: agonist for the fat regulator PPAR?.- 15 The role of leukotrienes in rhinitis.

Reviews

Author Information

Jack Botting is Consultant at the William Harvey Research Institute, an independent charitable foundation within Queen Mary and Westfield College of the University of London, UK.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions